Skip to main content
SpringerLink
Log in

High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

High-dose chemotherapy with autologous stem cell rescue (ASCR) is a promising strategy for patients with poor prognosis cerebellar medulloblastoma. For this strategy to be effective, it must be shown that the medulloblastoma tumor cells are sensitive to the chemotherapeutic agents whose dose-limiting toxicity is hematopoietic, and stem cells must be available that are free of contaminating tumor. Several protocols for high-dose chemotherapy followed by ASCR are presented in this chapter. Initial encouraging evaluations of this technique in patients with recurrent disease has prompted testing of its feasibility in infants and young children. In a reasonably short time, the role of high-dose chemotherapy with ASCR will be determined for subgroups of patients with medulloblastoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, Rorke LB, Evans AE, Schut L: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 433–440, 1991

    Google Scholar 

  2. Heideman RL, Packer RJ, Reaman GH, Allen JC, Lange B, Horowitz ME, Steinberg SM, Gillespie A, Kovnar EH, Balis FM, Poplack DG: A phase II evaluation of thiotepa in pediatric central nervous system malignancies. Cancer 72: 271–275, 1993

    Google Scholar 

  3. Torres CF, Rebsamen S, Silber JH, Sutton LN, Bilaniuk LT, Zimmerman RA, Goldwein JW, Phillips PC, Lange BJ: Surveillance scanning of children with medulloblastoma. N Engl J Med 330: 892–895, 1994

    Google Scholar 

  4. Belza MG, Donaldson SS, Steinberg GK, Cox RS, Cogen PH: Medulloblastoma: freedom from relapse longer than 8 years-a therapeutic cure? J Neurosurg 75: 575–582, 1991

    Google Scholar 

  5. Dunkel I, Garvin J, Allen J, Boyett J, Heller G, Yates A, Rosenblum M, Bayer L, Geyer J, Lindsley K, Goldman S, Sender L, Cowan M, Jennings M, Harris R, Bostrom B, Sanders J, Finlay JL: High dose chemotherapy with authologous stem cell rescue in patients with recurrent medulloblastoma (Abstract). SIOP 1995

  6. Bayer L, Petriccione M, Nirenberg A, Dunkel I, Finlay JL: Toxicities and supportive care issues in patients undergoing autologous stem cell rescue for malignant brain tumors (Abstract). SIOp 1995

  7. George D, Ginsberg J, Weingast R, Papadakis V, Gillio AP, Papadopoulos E, Heller G, Finlay JL: Multiorgan system failure syndrome in patients undergoing myeloablative chemotherapy and autologous bone marrow rescue for malignant brain tumors (Abstract). ISEH 1994

  8. Kalifa C, Hartmann O, Demeocq F, Vassel G, Couanet D, Terrier-Lacombe MJ, Valteau D, Brugieres L, Lemerle J: High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: a phase II study. Bone Marrow Transplant 9: 227–233, 1992

    Google Scholar 

  9. Mahoney D, Stroher D, Bowen T, Ghim T, Pick T, Wall D, Yu L, Friedman H: High dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a phase I–II pediatric oncology group study (Abstract). Proc Annu Meet Am Soc Clin Oncol 13: A484, 1994

    Google Scholar 

  10. Lundberg JH, Weissman DE, Beatty PA, Ash RC: Treatment of recurrent metastatic medulloblastoma with intensive chemotherapy and allogeneic bone marrow transplantation. J Neurooncol 13: 151–155, 1992

    Google Scholar 

  11. Cottu PH, Giachetti S, Mignot L, Epardeau B, Visot B, Extra JM, Espie M, Marty M: High dose chemotherapy with stem-cell transplantation in a metastatic medulloblastoma in an adult: a case report and review of the literature. J Neurooncol 18: 19–23, 1994

    Google Scholar 

  12. Santana VM, Schell MJ, Williams R, Bowman LC, Thompson EI, Brenner MK, Mirro J: Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Bone Marrow Transplant 10: 457–462, 1992

    Google Scholar 

  13. Wiley J, Fresia A, Strauss L, Civin C, Phillips P, Leventhal B: High-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow rescue in children and young adults with refractory solid or brain tumors (Abstract). Proc Annu Meet Am Soc Clin Oncol 11: A1292, 1992

    Google Scholar 

  14. Graham ML, Chaffee S, Kurtzberg J, Guaspari A, Friedman HS: A Phase I–II study of high-dose melphalan and cyclophosphamide with autologous bone marrow and/or stem cell rescue for patients with high-risk CNS tumors (Abstract). Proc Annu Meet Am Soc Clin Oncol 12: A523, 1993

    Google Scholar 

  15. Silber JH, Radcliffe J, Peckham V, Perilongo C, Kishnani P, Fridman M, Goldwein JW, Meadows AT: Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol 10: 1390–1396, 1992

    Google Scholar 

  16. Baram TZ, Van Eys J, Dowell RE, Cangir A, Pack B, Bruner JM: Survival and neurologic outcome of infants with medulloblastoma treated with surgery and MOPP chemotherapy: a preliminary report. Cancer 60: 173–177, 1987

    Google Scholar 

  17. Horowitz ME, Mulhern RK, Kun LE, Kovnar E, Sanford RA, Simmons J, Hayes FA, Jenkins JJ: Brain tumors in the very young child: postoperative chemotherapy in combined-modality treatment. Cancer 61: 428–434, 1988

    Google Scholar 

  18. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, Seidel FG, Kun LE: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725–1731, 1993

    Google Scholar 

  19. Geyer JR, Zeltzer PM, Boyett JM, Rorke LB, Stanley P, Albright AL, Wisoff JH, Milstein JM, Allen JC, Finlay JL, Ayers GD, Shurin SB, Stevens KR, Bleyer WA: Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the cns treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol 12: 1607–1615, 1994

    Google Scholar 

  20. Finlay JL, Grovas A, Garvin J, Dunkel I, Bayer L, Pucetti D, Halpern S, Drachtman R, Goldman S, Tugal O, Jayabose S, Weinblatt M, Sahdev I, Allen JC: The “head start” regimen for children less than six years of age newly-diagnosed with malignant brain tumors (Abstract). SIOP 1995

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

    Ira J. Dunkel & Jonathan L. Finlay

Authors
  1. Ira J. Dunkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jonathan L. Finlay
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dunkel, I.J., Finlay, J.L. High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma. J Neuro-Oncol 29, 69–74 (1996). https://doi.org/10.1007/BF00165519

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165519

Key words

Search

Navigation